Lung Cancer Screening.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28577626.
- Also identified by DOI 10.1016/j.mcna.2017.03.008 and PMC identifier 7368999.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lung cancer is the leading cause of cancer death in the United States. More than 80% of these deaths are attributed to tobacco use, and primary prevention can effectively reduce the cancer burden. The National Lung Screening Trial showed that low-dose computed tomography (LDCT) screening could reduce lung cancer mortality in high-risk patients by 20% compared with chest radiography. The US Preventive Services Task Force recommends annual LDCT screening for persons aged 55 to 80 years with a 30-pack-year smoking history, either currently smoking or having quit within 15 years.
Medical subject headings
- Early Detection of Cancer
- Lung Neoplasms
- Smoking